|1.||Hou, Qi: 1 article (07/2014)|
|2.||Cao, Shuhua: 1 article (07/2014)|
|3.||Bai, Jinye: 1 article (07/2014)|
|4.||Jiang, Rentao: 1 article (07/2014)|
|5.||Liu, Renping: 1 article (07/2014)|
|6.||Yuan, Shaopeng: 1 article (07/2014)|
|7.||Lin, Jiayuh: 1 article (03/2010)|
|8.||Shenoy, Satyendra S: 1 article (03/2010)|
|9.||Fuchs, James: 1 article (03/2010)|
|10.||Pandit, Bulbul: 1 article (03/2010)|
07/01/2014 - "Based on these results, we conclude that FLLL31 is a potential therapeutic agent that can be used against severe airway inflammation diseases. "
07/01/2014 - "Importantly, FLLL31 significantly inhibited airway inflammation and recruitment of inflammatory cells in the DRA-challenged mouse model. "
07/01/2014 - "However, the function of FLLL31 on inflammatory diseases, especially on the regulation of airway inflammation, has not been fully studied. "
07/01/2014 - "FLLL31, a derivative of curcumin, attenuates airway inflammation in a multi-allergen challenged mouse model."
|2.||Breast Neoplasms (Breast Cancer)
03/15/2010 - "Here we show that FLLL31 and FLLL32 are effective inhibitors of STAT3 phosphorylation, DNA-binding activity, and transactivation in vitro, leading to the impediment of multiple oncogenic processes and the induction of apoptosis in pancreatic and breast cancer cell lines. "
03/15/2010 - "FLLL31 and FLLL32 also inhibit colony formation in soft agar and cell invasion and exhibit synergy with the anticancer drug doxorubicin against breast cancer cells. "
|2.||DNA (Deoxyribonucleic Acid)